Compositions and devices of poly-4-hydroxybutyrate
Compositions of P4HB with high purity have been developed. The compositions are prepared by washing P4HB biomass prior to solvent extraction, and precipitating P4HB from solution. The same solvent is preferably used to wash the P4HB biomass, and as a non-solvent to precipitate the polymer from a P4HB solvent solution. The highly pure P4HB compositions are suitable for preparing implants. The implants may be used for the repair of soft and hard tissues.
1. A composition comprising a polyhydroxyalkanoate (PHA) polymer obtained by a process comprising: suspending a PHA polymer biomass in ethanol for a period of time effective to extract lipids into the ethanol, separating the PHA polymer biomass from the ethanol by solid-liquid separation, collecting the ethanol-washed biomass, and extracting the PHA polymer into a solvent.
2. The composition of claim 1 wherein the polymer is precipitated with a non-solvent for the polymer, harvested, and dried.
3. The composition of claim 2 , wherein the polymer does not lose more than 10% of its weight average molecular weight during recovery.
4. The composition of claim 1 wherein the weight average molecular weight of the polymer is from 50,000 to 1.2 million Da.
5. The composition of claim 1 wherein the composition is sterilized with cold ethylene oxide gas, gamma-irradiation, or electron beam irradiation.
6. The composition of claim 5 wherein the biomass is derived from a microorganism.
7. The composition of claim 1 wherein the composition is a coating for a medical device.
8. The composition of claim 1 wherein the biomass is suspended in ethanol for one hour at ambient temperature.
9. The composition of claim 1 wherein the PHA polymer is poly-4-hydroxybutyrate (P4HB) polymer.
10. The composition of claim 9 wherein the composition comprises P4HB homopolymer.
11. The composition of claim 9 wherein the endotoxin content of the composition is less than 0.22 endotoxin units (EU)/g of the composition.
12. A medical device comprising the composition of claim 1 wherein the device is selected from the group consisting of: suture, barbed suture, braided suture, monofilament suture, hybrid suture of monofilament and multifilament fibers, braids, ligatures, knitted or woven meshes, knitted tubes, catheters, monofilament meshes, multifilament meshes, patches, wound healing device, bandage, wound dressing, burn dressing, ulcer dressing, skin substitute, hemostat, tracheal reconstruction device, organ salvage device, dural substitute, dural patch, nerve guide, nerve regeneration or repair device, hernia repair device, hernia mesh, hernia plug, device for temporary wound or tissue support, tissue engineering scaffold, guided tissue repair/regeneration device, anti-adhesion membrane, adhesion barrier, tissue separation membrane, retention membrane, sling, device for pelvic floor reconstruction, urethral suspension device, device for treatment of urinary incontinence, device for treatment of vesicoureteral reflux, bladder repair device, sphincter muscle repair device, injectable particles, injectable microspheres, bulking or filling device, bone marrow scaffold, clip, clamp, screw, pin, nail, medullary cavity nail, bone plate, interference screw, tack, fastener, rivet, staple, fixation device for an implant, bone graft substitute, bone void filler, suture anchor, bone anchor, ligament repair device, ligament augmentation device, ligament graft, anterior cruciate ligament repair device, tendon repair device, tendon graft, tendon augmentation device, rotator cuff repair device, meniscus repair device, meniscus regeneration device, articular cartilage repair device, osteochondral repair device, spinal fusion device, device for treatment of osteoarthritis, viscosupplement, stent, including coronary, cardiovascular, peripheral, ureteric, urethral, urology, gastroenterology, nasal, ocular, or neurology stents and stent coatings, stent graft, cardiovascular patch, catheter balloon, vascular closure device, intracardiac septal defect repair device, including but not limited to atrial septal defect repair devices and PFO (patent foramen ovale) closure devices, left atrial appendage (LAA) closure device, pericardial patch, vein valve, heart valve, vascular graft, myocardial reneration device, periodontal mesh, guided tissue regeneration membrane for periodontal tissue, ocular cell implant, imaging device, cochlear implant, embolization device, anastomosis device, cell seeded device, cell encapsulation device, controlled release device, drug delivery device, plastic surgery device, breast lift device, mastopexy device, breast reconstruction device, breast augmentation device, devices for use with breast implants, breast reduction device, devices for removal, reshaping and reorienting breast tissue, devices for breast reconstruction following mastectomy with or without breast implants, facial reconstructive device, forehead lift device, brow lift device, eyelid lift device, face lift device, rhytidectomy device, thread lift device to lift and support sagging areas of the face, brow and neck, rhinoplasty device, device for malar augmentation, otoplasty device, neck lift device, mentoplasty device, cosmetic repair device, and device for facial scar revision.
13. The medical device of claim 12 wherein the PHA polymer is poly-4-hydroxybutyrate.
14. The medical device of claim 13 comprising a fiber wherein the fiber has a tensile strength of greater than 126 MPa or a yarn wherein the tenacity of the yarn is greater than 0.5 grams per denier.
15. A process for purifying PHA polymer from a biomass comprising suspending a PHA polymer biomass in ethanol for a period of time effective to extract lipids into the ethanol, separating the PHA polymer biomass from the ethanol by solid-liquid separation, collecting the ethanol-washed biomass, and extracting the PHA polymer into a solvent.
16. The process of claim 15 , comprising suspending the biomass in ethanol for one hour at ambient temperature.
17. The process of claim 16 wherein the biomass is washed with at least 4 grams of ethanol per gram of biomass.
18. The process of claim 15 wherein the wt/wt ratio of PHA polymer biomass to ethanol is 1:1.
19. The process of claim 15 , further comprising precipitating the polymer from the solvent with a non-solvent for the polymer, and drying the polymer.
20. The process of claim 19 , wherein the ratio of non-solvent for the polymer to the solvent ranges from 1:2 to 4:1.
21. The process of claim 20 , wherein the ratio of the non-solvent for the polymer to the solvent is 1:1.
22. The process of claim 15 wherein the solvent is selected from the group consisting of methylene chloride, chloroform, tetrahydrofuran, acetone, dioxane, ethyl acetate, dimethylene carbonate, dimethyl sulfoxide, dimethyl formamide, methyl ethyl ketone, butyl acetate, butyl propionate and diethyl carbonate, and wherein the non-solvent for the polymer is an alcohol, aqueous alcohol, or water.